BANK OF AMERICA CORP /DE/
BankPosition in ARQT — Arcutis Biotherapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in ARQT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$78,330,439
+$25,996,872 QoQ
Shares Held
2,987,431
+34.5% QoQ
Ownership
2.38%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 271 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Derivatives in ARQT
reported options exposure · as of Mar 31, 2021CallValue
$347,160
CallShares
12,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. ARQT ranks #30 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ARQT
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,330,439 | 2,987,431 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $52,333,567 | 2,221,289 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $48,597,101 | 1,673,454 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,763,020 | 889,285 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $16,859,230 | 1,202,513 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,053,831 | 514,951 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,472,857 | 536,458 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,935,915 | 1,175,905 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,274,242 | 567,123 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,428,740 | 850,529 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $293,986 | 91,018 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,863,611 | 350,963 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,874,466 | 406,555 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,839,514 | 1,621,774 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,537,761 | 239,038 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,890,519 | 151,257 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $816,064 | 38,295 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $192,598 | 10,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $251,160 | 12,110 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $155,522 | 6,510 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $178,284 | 6,533 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $878,341 | 30,361 | Shares | Defined | 2021-05-14 | |
| 2021-03-31 | $347,160 | 12,000 | Call | Defined | 2021-05-14 | |
| 2020-12-31 | $140,789 | 5,005 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $132,405 | 4,519 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $114,185 | 3,776 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $139,225 | 4,672 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||